Carlsmed, Inc. Common Stock (CARL) is a publicly traded Healthcare sector company. As of May 21, 2026, CARL trades at $11.77 with a market cap of $297.13M and a P/E ratio of -5.59. CARL moved +4.07% today. Year to date, CARL is -2.65%; over the trailing twelve months it is flat. Its 52-week range spans $8.50 to $17.19. Analyst consensus is strong buy with an average price target of $18.40. Rallies surfaces CARL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for CARL combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $11.77 |
| Market Cap | $297.13M |
| P/E Ratio | -5.59 |
| EPS | $-2.12 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.19 |
| 52-Week Low | $8.50 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $50.51M |
| Net Income | $-29.63M |
| Gross Margin | 75.31% |
5 analysts cover CARL: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $18.40.